Biocytogen's Japan Patent Boosts Ideaya Shares 2.89%!

viernes, 6 de junio de 2025, 10:42 am ET1 min de lectura
IDYA--
Ideaya Biosciences, Inc. rose 2.89% during intraday trading. The recent news event about BiocytogenBIIB-- Pharmaceuticals Beijing securing a Japan patent may have positively influenced the stock price, as it indicates a successful drug development process and potential market expansion for the company.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios